The collaboration aims to provide the clinical laboratory market with an integrated workflow to support next generation sequencing-based tests.
Ingenuity will provide content and software for the analysis and biological interpretation of variants from sequencing-based tests while GeneInsight will provide genetic testing laboratories and providers with networked infrastructure to support interpretation, reporting, and management of genetic data under the collaboration.
Partners’ Laboratory for Molecular Medicine chief laboratory director Heidi Rehm said the combined solution will incorporate knowledge about genomic variation from the Ingenuity offering with GeneInsight’s knowledge management and reporting infrastructure, helping to streamline the overall workflow for very broad spectrum tests.
"With the collaboration between GeneInsight and Illumina announced last fall, this truly integrated solution will go a long way towards making NGS-based technology more accessible in the clinic," Rehm added.
GeneInsight is a wholly owned subsidiary of Partners HealthCare and develops software to support reporting for genetic testing laboratories.